Go Deep
Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 18,297 | -38.3 | 4.66 | 0.00 | 7,446.32 |
| Oct 2026 | 18,408 | -37.6 | 4.57 | 0.00 | 7,280.57 |
| Oct 2026 | 18,614 | -36.9 | 4.40 | 0.00 | 7,014.77 |
| Oct 2026 | 18,757 | -35.3 | 4.28 | 0.00 | 6,812.85 |
| Oct 2026 | 18,570 | -36.5 | 4.44 | 0.00 | 7,061.92 |
| Oct 2026 | 18,231 | -38.8 | 4.71 | 0.00 | 7,499.03 |
| Oct 2026 | 18,169 | -39.2 | 4.76 | 0.00 | 7,559.01 |
| Oct 2026 | 18,079 | -39.8 | 4.83 | 0.00 | 7,659.82 |
Oruka Therapeutics, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -41,206,000.0 | -31,820,000.0 | -29,583,000.0 | -30,277,000.0 |
| EPS | -0.6 | -0.5 | — | -0.6 |
Oruka Therapeutics, Inc. Revenue & Profit: Last 1 Year
| Line Item | Dec 2025 |
|---|---|
| Revenue | 0.0 |
| Net Profit | -105,433,000.0 |
| EPS | -1.9 |
Oruka Therapeutics, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Total Assets | 488,617,000.0 | 396,019,000.0 |
| Total Liabilities | 19,618,000.0 | 16,729,000.0 |
| Total Equity | 468,999,000.0 | 379,290,000.0 |
Owes vs Owns
Oruka Therapeutics, Inc. owed $0.02 for every $1 it owned in Jun 2026, down from $0.04 in Dec 2024.
| Period | Jun 2026 | Dec 2025 | Dec 2024 |
|---|---|---|---|
| Owes vs Owns | 0.02× | 0.04× | 0.04× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Oruka Therapeutics, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 69.0%Long-term investments 29.2%Other assets 1.4%
How it's funded — Dec 2025
Payables 0.9%Other liabilities 2.8%Shareholders' equity 96.0%
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Assets | ||
| Cash & short-term investments | 337.0 | 375.6 |
| Receivables | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 |
| Fixed assets (tangible) | 2.1 | 1.0 |
| Intangible assets | 0.0 | 0.0 |
| Long-term investments | 142.5 | 18.1 |
| Other assets | 6.9 | 1.3 |
| Liabilities & equity | ||
| Short-term debt | 0.6 | 0.2 |
| Long-term debt | 1.3 | 0.8 |
| Payables | 4.2 | 3.5 |
| Other liabilities | 13.5 | 12.3 |
| Shareholders' equity | 469.0 | 379.3 |
| Net tangible assets | 469.0 | 379.3 |
Oruka Therapeutics, Inc. Cash Flow
| Line Item | Dec 2025 |
|---|---|
| Operating Activities | -88,210,000.0 |
| Investing Activities | -96,745,000.0 |
| Financing Activities | 170,315,000.0 |